openPR Logo
Press release

Advancements In Technology To Be The Humdinger Of Non Opioid Analgesics Market

09-29-2021 05:23 PM CET | Health & Medicine

Press release from: Persistence Market Research

Advancements In Technology To Be The Humdinger Of Non Opioid

Analgesics are the drugs used for the management of the pain. Pain is one of the most common phenomenon and around 85% of people are reported to suffer from pain worldwide at some point in their life. Pain can be of various types such as due to surgery, strain, etc. Non-opioid analgesics are the drugs which are used for relieving pain, since use of most of the opioid drugs is abused at some stage by patient or any other person for non-medical use hence usage of opioid drugs is advised to lower by various healthcare professionals.

More than 56% of people across the world are reported to experience the body pain once a week whereas head pain affects around 23% once a week. More than 70,000 Americans died due to opioid abuse in 2017, which resulted in stringent regulatory measures by various regulatory bodies.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/28657

Increasing prevalence of the various chronic diseases such as cancer in which various treatments such as chemotherapy is responsible for the pain expected to drive the growth of the non-opioid analgesics market. Increasing number of surgeries is expected to result in increased prevalence of post-operative pain which in turn expected to drive the growth of the non-opioid analgesics market. Increasing number of people suffering from neuropathic pain further expected to fuel the growth of non-opioid analgesics market.

Additional regulatory impositions on the opioid drugs is responsible for their limited market reach which in turn expected to drive the growth of the non-opioid analgesics market. Increasing support of various advocacy groups and KOLs to the non-opioid analgesics expected to drive the growth of the non-opioid analgesics market. Lower cost of the non-opioid analgesics as compared to opioid drugs further expected to drive the growth of the non-opioid analgesics market.

Worldwide reach of various regional and global non-opioid analgesics manufacturers resulted in the easy access to these drugs driving the growth of the non-opioid analgesics market. Whereas, frequent use of non-opioid analgesics is linked to various conditions such as decreased kidney functioning, increased risk of stroke, etc. may hamper the growth of the market.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/28657

Market Segmentation:

By drug class

NSAIDs
Acetaminophen
Local Anaesthetics

By pain type

Post-operative Pain
Cancer Pain
Neuropathic Pain
Others

By route of administration

Oral
Topical
Injectable

By distribution channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

Access Full Report@ https://www.persistencemarketresearch.com/checkout/28657

The global non-opioid analgesics market is expected to be dominated by the North America due to higher prevalence of the pain. Europe is expected to be the second most lucrative region in the global non-opioid analgesics market owing to higher adoption of the analgesics.

Asia-Pacific is expected to be the fastest growing non-opioid analgesics market due to large population residing in countries such as India and China. Latin America market is expected to experience steady growth whereas MEA expected to be the least lucrative market due to lower adoption.

The key participants operating in the global non-opioid analgesics market are: Iroko Pharmaceuticals, LLC, Pfizer Inc., Johnson & Johnson, MERCK, MIPHARM S.p.A., Novartis AG, Teva Pharmaceuticals, Mylan NV, and others.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Advancements In Technology To Be The Humdinger Of Non Opioid Analgesics Market here

News-ID: 2412017 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and